S-Alpha Therapeutics, Inc , Digital Therapeutics Start-up Raises $8 7 Million in Series A Funding apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Backers included Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment.
The company intends to use funds to execute clinical trials in the US to study their development stage digital therapeutic application intended to treat eye disease.
Led by Seung Eun Choi, CEO, and Dr. Myung Joon Kim, Chief Medical Officer, S-Alpha is a digital therapeutics company with platform technologies that enable digital devices to treat different diseases. S-Alpha has a pipeline of products in the areas of ophthalmology, neuropsychiatry, cancer, and immunology.
Its lead product, SAT-001, is currently in the process of regulatory submission to start clinical studies in Korea as a therapeutic device for treating eye disease following MFDS’s guidance in June 2020.